357 related articles for article (PubMed ID: 26351858)
41. Localized and persistent erythema nodosum leprosum - a rare variant?
Prabhu S; Rao R; Sripathi H; Rao L; Singh R
Dermatol Online J; 2008 Mar; 14(3):16. PubMed ID: 18627717
[TBL] [Abstract][Full Text] [Related]
42. The mortality associated with erythema nodosum leprosum in Ethiopia: a retrospective hospital-based study.
Walker SL; Lebas E; Doni SN; Lockwood DN; Lambert SM
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2690. PubMed ID: 24625394
[TBL] [Abstract][Full Text] [Related]
43. Towards understanding the pathology of erythema nodosum leprosum.
Kahawita IP; Lockwood DN
Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):329-37. PubMed ID: 18313706
[TBL] [Abstract][Full Text] [Related]
44. Erythema nodosum leprosum and HIV infection: A therapeutic experience.
Sharma NL; Mahajan VK; Sharma VC; Sarin S; Sharma RC
Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):189-93. PubMed ID: 16830640
[TBL] [Abstract][Full Text] [Related]
45. Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function.
Negera E; Bobosha K; Aseffa A; Dockrell HM; Lockwood DNJ; Walker SL
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010641. PubMed ID: 35867720
[TBL] [Abstract][Full Text] [Related]
46. [Erythema nodosum leprosum case series report: clinical profile, immunological basis and treatment implemented in health services].
Guerra JG; Penna GO; Castro LC; Martelli CM; Stefani MM; Costa MB
Rev Soc Bras Med Trop; 2004; 37(5):384-90. PubMed ID: 15361954
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the efficacy and safety of minocycline and clofazimine in chronic and recurrent erythema nodosum leprosum-A randomized clinical trial.
Hanumanthu V; Thakur V; Narang T; Dogra S
Dermatol Ther; 2021 Nov; 34(6):e15125. PubMed ID: 34490707
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis of erythema nodosum leprosum (type 2 reaction) by cytology.
Ray R; Mondal RK; Pathak S
Acta Cytol; 2014; 58(1):29-32. PubMed ID: 24247108
[TBL] [Abstract][Full Text] [Related]
49. Erythema nodosum leprosum: a possible cause of oral destruction in leprosy.
Scheepers A; Lemmer J
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):641-3. PubMed ID: 1299716
[TBL] [Abstract][Full Text] [Related]
50. Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients.
Hossain D
Lepr Rev; 2013 Mar; 84(1):105-12. PubMed ID: 23741889
[TBL] [Abstract][Full Text] [Related]
51. Elevated Pentraxin-3 Concentrations in Patients With Leprosy: Potential Biomarker of Erythema Nodosum Leprosum.
Mendes MA; de Carvalho DS; Amadeu TP; Silva BJA; Prata RBDS; da Silva CO; Ferreira H; Hacker MA; Nery JAC; Pinheiro RO; Sampaio EP; Sarno EN; Schmitz V
J Infect Dis; 2017 Dec; 216(12):1635-1643. PubMed ID: 29272525
[TBL] [Abstract][Full Text] [Related]
52. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
Job CK; Jacobson RR; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
[TBL] [Abstract][Full Text] [Related]
53. Erythema Nodosum Leprosum as a Rare and Challenging Cause of Pyrexia of Unknown Origin.
Narangr H; Sethi P; Rastogi N; Arava S; Kumar A; Nischal N; Wig N
J Assoc Physicians India; 2018 Apr; 66(4):63-6. PubMed ID: 30347957
[TBL] [Abstract][Full Text] [Related]
54. Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
Hungria EM; Oliveira RM; Penna GO; Aderaldo LC; Pontes MA; Cruz R; Gonçalves HS; Penna ML; Kerr LR; Stefani MM; Bührer-Sékula S
Infect Dis Poverty; 2016 Dec; 5(1):110. PubMed ID: 27919284
[TBL] [Abstract][Full Text] [Related]
55. Canadian case report of erythema nodosum leprosum successfully treated with prednisone and thalidomide.
Saber M; Bourassa-Fulop C; Bouffard D; Provost N
J Cutan Med Surg; 2010; 14(2):95-9. PubMed ID: 20338126
[TBL] [Abstract][Full Text] [Related]
56. [Review: update on erythema nodosum leprosum].
Morand JJ; Badiane C; Bobin P
Med Trop (Mars); 2004; 64(5):423-30. PubMed ID: 15771008
[TBL] [Abstract][Full Text] [Related]
57. Leukemoid reaction in erythema nodosum leprosum in a leprosy patient.
Chaudhary SD; Sen R; Jain VK; Dixit VB
Indian J Lepr; 1988 Oct; 60(4):572-6. PubMed ID: 3253336
[TBL] [Abstract][Full Text] [Related]
58. Bullous Erythema Nodosum Leprosum as the First Manifestation of Multibacillary Leprosy: A Rare Phenomenon.
Bakshi N; Rao S; Batra R
Am J Dermatopathol; 2017 Nov; 39(11):857-859. PubMed ID: 28763338
[TBL] [Abstract][Full Text] [Related]
59. Erythema leprosum--after treatment of Lepromatous Leprosy.
Eickelmann M; Steinhoff M; Metze D; Tomimori-Yamashita J; Sunderkötter C
J Dtsch Dermatol Ges; 2010 Jun; 8(6):450-3. PubMed ID: 19922466
[TBL] [Abstract][Full Text] [Related]
60. Histoid leprosy with erythema nodosum leprosum--a case report.
Vasavi S; Reddy BS
Indian J Lepr; 2012; 84(1):27-9. PubMed ID: 23077781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
